Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Knauf

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Blood|November 1, 1989
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemiaM Körbling, W Hunstein, T M Fliedner, et al.
Blood|February 25, 1999
Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemiaM Hallek, I Langenmayer, C Nerl, et al.
British Journal of Haematology|August 1, 1996
Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre studyI Langenmayer, C Nerl, W Knauf, et al.
Deutsche Medizinische Wochenschrift (1946)|August 16, 1991
[Malignant lymphoma associated with HIV infection]P S Mitrou, M Serke, C Pohl, et al.
Leukemia & Lymphoma|June 25, 1998
HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b/zidovudine maintenance therapyR Weiss, D Huhn, P Mitrou, et al.
Blood|August 25, 2001
Rituximab therapy of patients with B-cell chronic lymphocytic leukemiaD Huhn, C von Schilling, M Wilhelm, et al.
Der Internist|January 15, 2003
[Chronic lymphatic leukemia. Current therapy concepts]M Hallek, M Bergmann, G Brittinger, et al.
Annals of Hematology|May 6, 2004
Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantationJ Casper, W Knauf, I Blau, et al.
Leukemia|November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseR Arnold, G Massenkeil, M Bornhäuser, et al.
British Journal of Haematology|September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupM Hallek, B Schmitt, M Wilhelm, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Blood|November 1, 1989
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemiaM Körbling, W Hunstein, T M Fliedner, et al.
Blood|February 25, 1999
Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemiaM Hallek, I Langenmayer, C Nerl, et al.
British Journal of Haematology|August 1, 1996
Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre studyI Langenmayer, C Nerl, W Knauf, et al.
Deutsche Medizinische Wochenschrift (1946)|August 16, 1991
[Malignant lymphoma associated with HIV infection]P S Mitrou, M Serke, C Pohl, et al.
Leukemia & Lymphoma|June 25, 1998
HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b/zidovudine maintenance therapyR Weiss, D Huhn, P Mitrou, et al.
Blood|August 25, 2001
Rituximab therapy of patients with B-cell chronic lymphocytic leukemiaD Huhn, C von Schilling, M Wilhelm, et al.
Der Internist|January 15, 2003
[Chronic lymphatic leukemia. Current therapy concepts]M Hallek, M Bergmann, G Brittinger, et al.
Annals of Hematology|May 6, 2004
Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantationJ Casper, W Knauf, I Blau, et al.
Leukemia|November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseR Arnold, G Massenkeil, M Bornhäuser, et al.
British Journal of Haematology|September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupM Hallek, B Schmitt, M Wilhelm, et al.
Pageof 7